Handelen SEELOS THERAPEUTICS INC - SEEL CFD
Toevoegen aan favorieten- Samenvatting
- Historische gegevens
- Evenementen
- Winst- en verliesrekening
- Balans
- Cash Flow
- Eigendom
Spread | 0.0163 | ||||||||
Overnight-tarief longpositie
Long position overnight fee
Ga naar platform | -0.025457% | ||||||||
Overnight-tarief shortpositie
Short position overnight fee
Ga naar platform | 0.003235% | ||||||||
Tijd van overnight-tarief | 21:00 (UTC) | ||||||||
Min. verhandelde hoeveelheid | 1 | ||||||||
Valuta | USD | ||||||||
Marge | 20% | ||||||||
Effectenbeurs | United States of America | ||||||||
Handelscommissie | 0% |
*Information provided by Capital.com
Seelos Therapeutics Inc ESG Risk Ratings
‘D’ score indicates poor relative ESG performance and insufficient degree of transparency in reporting material ESG data publicly.
Prev. Close* | 0.8542 |
Open* | 0.8491 |
1-Jaarlijkse Verandering* | 43.92% |
Dagelijks bereik* | 0.8491 - 0.8984 |
52 wekelijks bereik | 0.58-1.52 |
Weekgemiddelde volume (10 dagen) | 492.01K |
Gemiddeld volume (3 maanden) | 10.76M |
Marktkapitalisatie | 112.66M |
P/E Ratio | -100.00K |
Uitstaande Aandelen | 121.81M |
Omzet | 808.00K |
EPS | -0.68 |
Dividend (opbrengst %) | N/A |
Beta | 1.74 |
Volgende inkomsten datum | Aug 3, 2023 |
Alle gegevens zijn afkomstig van Refinitiv, behalve de gegevens gemarkeerd met een sterretje, die zijn afkomstig van Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Slotkoers | Change | Change (%) | Openingskoers | High | Low |
---|---|---|---|---|---|---|
May 30, 2023 | 0.8542 | -0.0309 | -3.49% | 0.8851 | 0.8950 | 0.8062 |
May 26, 2023 | 0.9122 | 0.0167 | 1.86% | 0.8955 | 0.9370 | 0.8686 |
May 25, 2023 | 0.8686 | -0.0662 | -7.08% | 0.9348 | 0.9447 | 0.8686 |
May 24, 2023 | 0.8982 | -0.0541 | -5.68% | 0.9523 | 0.9616 | 0.8710 |
May 23, 2023 | 0.9887 | 0.0102 | 1.04% | 0.9785 | 0.9985 | 0.9735 |
May 22, 2023 | 0.9763 | -0.0182 | -1.83% | 0.9945 | 1.0284 | 0.9317 |
May 19, 2023 | 0.9836 | -0.0448 | -4.36% | 1.0284 | 1.0584 | 0.9835 |
May 18, 2023 | 1.0384 | 0.0959 | 10.18% | 0.9425 | 1.0783 | 0.9425 |
May 17, 2023 | 0.9676 | 0.0874 | 9.93% | 0.8802 | 0.9676 | 0.8741 |
May 16, 2023 | 0.8915 | 0.0163 | 1.86% | 0.8752 | 0.9057 | 0.8588 |
May 15, 2023 | 0.8782 | 0.0180 | 2.09% | 0.8602 | 0.9027 | 0.8219 |
May 12, 2023 | 0.8383 | -0.0311 | -3.58% | 0.8694 | 0.8758 | 0.8298 |
May 11, 2023 | 0.8577 | -0.0473 | -5.23% | 0.9050 | 0.9140 | 0.8429 |
May 10, 2023 | 0.9058 | 0.0998 | 12.38% | 0.8060 | 0.9269 | 0.8060 |
May 9, 2023 | 0.8144 | 0.0029 | 0.36% | 0.8115 | 0.8288 | 0.7787 |
May 8, 2023 | 0.8120 | -0.0107 | -1.30% | 0.8227 | 0.8329 | 0.8083 |
May 5, 2023 | 0.8239 | 0.0565 | 7.36% | 0.7674 | 0.8420 | 0.7619 |
May 4, 2023 | 0.7678 | 0.0220 | 2.95% | 0.7458 | 0.7770 | 0.7140 |
May 3, 2023 | 0.7381 | 0.0206 | 2.87% | 0.7175 | 0.7655 | 0.7091 |
May 2, 2023 | 0.7209 | 0.0530 | 7.94% | 0.6679 | 0.7329 | 0.6679 |
SEELOS THERAPEUTICS INC Events
Tijd (UTC) (UTC) | Land | Evenement |
---|---|---|
Thursday, June 8, 2023 | ||
Tijd (UTC) (UTC) 13:00 | Land US
| Evenement Seelos Therapeutics Inc at Jefferies Healthcare Conference Seelos Therapeutics Inc at Jefferies Healthcare ConferenceForecast -Previous - |
- Jaarlijks
- Per kwartaal
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Totale inkomsten | 0 | 0 | 0 | 0.375 | 0 |
Totale bedrijfskosten | 70.916 | 63.907 | 18.759 | 30.122 | 3.184 |
Verkoop/Algemeen/Admin. Uitgaven, Totaal | 12.296 | 15.02 | 7.775 | 7.559 | 2.631 |
Onderzoek & Ontwikkeling | 58.62 | 46.649 | 10.984 | 22.563 | 0.553 |
Ongebruikelijke uitgaven (inkomsten) | 0 | 2.238 | |||
Bedrijfsresultaat | -70.916 | -63.907 | -18.759 | -29.747 | -3.184 |
Renteopbrengsten (-uitgaven), netto Niet-operationeel | 0.107 | -1.854 | -0.119 | 0.013 | -0.291 |
Overige, Netto | -2.725 | -0.287 | -0.223 | -21.521 | 0 |
Netto inkomen voor belastingen | -73.534 | -66.048 | -19.101 | -51.255 | -3.475 |
Netto inkomen na belastingen | -73.534 | -66.048 | -19.101 | -51.255 | -3.475 |
Netto inkomen voor extra. Posten | -73.534 | -66.048 | -19.101 | -51.255 | -3.475 |
Totale buitengewone posten | |||||
Netto inkomen | -73.534 | -66.048 | -19.101 | -51.255 | -3.475 |
Inkomsten beschikbaar voor gewone aandelen Excl. Extra. Posten | -73.534 | -66.048 | -19.101 | -51.255 | -3.475 |
Inkomsten beschikbaar voor gewone aandelen Incl. Extra. Posten | -73.534 | -66.048 | -19.101 | -51.255 | -3.475 |
Verwaterd Netto Inkomen | -73.534 | -66.048 | -19.101 | -51.255 | -3.475 |
Verwaterd Gewogen Gemiddelde Aandelen | 106.342 | 90.8901 | 44.7666 | 20.3088 | 3.08155 |
Verwaterde Winst per Aandeel Exclusief Buitengewone Posten | -0.69148 | -0.72668 | -0.42668 | -2.52378 | -1.12768 |
Verwaterde Genormaliseerde Winst per Aandeel | -0.69148 | -0.70206 | -0.42668 | -2.52378 | -1.12768 |
Inkomsten | 0 | 0.375 | 0 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Totale inkomsten | 0.808 | 0 | 0 | 0 | 0 |
Totale bedrijfskosten | 9.753 | 18.257 | 17.41 | 21.239 | 14.01 |
Verkoop/Algemeen/Admin. Uitgaven, Totaal | 4.072 | 2.752 | 2.66 | 2.883 | 4.001 |
Onderzoek & Ontwikkeling | 5.668 | 15.505 | 14.75 | 18.356 | 10.009 |
Bedrijfsresultaat | -8.945 | -18.257 | -17.41 | -21.239 | -14.01 |
Renteopbrengsten (-uitgaven), netto Niet-operationeel | 0.06 | 0.04 | 0.034 | 0.014 | 0.019 |
Overige, Netto | -4.546 | -0.44 | -2.228 | -0.047 | -0.01 |
Netto inkomen voor belastingen | -13.431 | -18.657 | -19.604 | -21.272 | -14.001 |
Netto inkomen na belastingen | -13.431 | -18.657 | -19.604 | -21.272 | -14.001 |
Netto inkomen voor extra. Posten | -13.431 | -18.657 | -19.604 | -21.272 | -14.001 |
Netto inkomen | -13.431 | -18.657 | -19.604 | -21.272 | -14.001 |
Inkomsten beschikbaar voor gewone aandelen Excl. Extra. Posten | -13.431 | -18.657 | -19.604 | -21.272 | -14.001 |
Inkomsten beschikbaar voor gewone aandelen Incl. Extra. Posten | -13.431 | -18.657 | -19.604 | -21.272 | -14.001 |
Verwaterd Netto Inkomen | -13.431 | -18.657 | -19.604 | -21.272 | -14.001 |
Verwaterd Gewogen Gemiddelde Aandelen | 112.52 | 107.067 | 106.69 | 106.069 | 105.53 |
Verwaterde Winst per Aandeel Exclusief Buitengewone Posten | -0.11936 | -0.17425 | -0.18375 | -0.20055 | -0.13267 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
Verwaterde Genormaliseerde Winst per Aandeel | -0.11925 | -0.17425 | -0.18375 | -0.20055 | -0.13267 |
Ongebruikelijke uitgaven (inkomsten) | 0.013 | 0 | 0 | 0 | |
Inkomsten | 0.808 |
- Jaarlijks
- Per kwartaal
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Totaal vlottende activa | 22.674 | 83.461 | 17.494 | 11.096 | 0.191 |
Geldmiddelen en kortetermijnbeleggingen | 15.533 | 78.734 | 15.662 | 10.261 | 0.042 |
Geldmiddelen & Equivalenten | |||||
Prepaid Expenses | 6.941 | 4.54 | 1.832 | 0.835 | 0.009 |
Other Current Assets, Total | 0.2 | 0.187 | 0 | 0.14 | |
Total Assets | 22.746 | 83.5 | 17.494 | 11.096 | 0.191 |
Property/Plant/Equipment, Total - Net | 0.072 | 0.039 | |||
Property/Plant/Equipment, Total - Gross | |||||
Accumulated Depreciation, Total | |||||
Other Long Term Assets, Total | |||||
Total Current Liabilities | 25.158 | 8.287 | 7.429 | 10.778 | 4.897 |
Accounts Payable | 3.626 | 1.693 | 1.887 | 0.796 | 2.22 |
Accrued Expenses | 7.34 | 3.766 | 1.924 | 1.919 | 0.235 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities, Total | 2.327 | 1.798 | 1.187 | 8.063 | 0 |
Total Liabilities | 33.357 | 26.177 | 14.922 | 11.103 | 4.897 |
Total Long Term Debt | 8.184 | 17.89 | 7.293 | 0 | 0 |
Other Liabilities, Total | 0.015 | 0 | 0.2 | 0.325 | 0 |
Total Equity | -10.611 | 57.323 | 2.572 | -0.007 | -4.706 |
Preferred Stock - Non Redeemable, Net | 0 | 0 | 0 | 0 | |
Common Stock | 0.107 | 0.105 | 0.054 | 0.027 | 0.003 |
Additional Paid-In Capital | 204.026 | 198.428 | 77.68 | 56.027 | 0.097 |
Retained Earnings (Accumulated Deficit) | -214.744 | -141.21 | -75.162 | -56.061 | -4.806 |
Total Liabilities & Shareholders’ Equity | 22.746 | 83.5 | 17.494 | 11.096 | 0.191 |
Total Common Shares Outstanding | 107.168 | 105.5 | 54.5359 | 27.0285 | 3.08155 |
Cash | 15.533 | 78.734 | 15.662 | 10.261 | 0.042 |
Current Port. of LT Debt/Capital Leases | 11.865 | 1.03 | 2.431 | 0 | 2.442 |
Long Term Debt | 8.184 | 17.89 | 7.293 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Totaal vlottende activa | 23.583 | 22.674 | 40.508 | 52.654 | 70.667 |
Geldmiddelen en kortetermijnbeleggingen | 14.059 | 15.533 | 30.511 | 41.251 | 61.772 |
Cash | 14.059 | 15.533 | 30.511 | 41.251 | 61.772 |
Prepaid Expenses | 8.352 | 6.941 | 9.583 | 10.863 | 8.481 |
Total Assets | 23.641 | 22.746 | 40.508 | 52.667 | 70.693 |
Property/Plant/Equipment, Total - Net | 0.058 | 0.072 | 0 | 0.013 | 0.026 |
Total Current Liabilities | 39.2 | 25.158 | 21.887 | 14.627 | 10.13 |
Accounts Payable | 5.963 | 3.626 | 5.952 | 2.306 | 2.127 |
Accrued Expenses | 5.659 | 7.34 | 4.048 | 3.733 | 3.575 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 11.62 | 11.865 | 10.655 | 7.447 | 4.238 |
Other Current Liabilities, Total | 15.958 | 2.327 | 1.232 | 1.141 | 0.19 |
Total Liabilities | 44.299 | 33.357 | 32.629 | 26.44 | 25.056 |
Total Long Term Debt | 5.099 | 8.184 | 10.742 | 11.813 | 14.926 |
Long Term Debt | 5.099 | 8.184 | 10.742 | 11.813 | 14.926 |
Other Liabilities, Total | 0 | 0.015 | |||
Total Equity | -20.658 | -10.611 | 7.879 | 26.227 | 45.637 |
Preferred Stock - Non Redeemable, Net | 0 | 0 | 0 | ||
Common Stock | 0.122 | 0.107 | 0.107 | 0.106 | 0.105 |
Additional Paid-In Capital | 207.395 | 204.026 | 203.859 | 202.604 | 200.743 |
Retained Earnings (Accumulated Deficit) | -228.175 | -214.744 | -196.087 | -176.483 | -155.211 |
Total Liabilities & Shareholders’ Equity | 23.641 | 22.746 | 40.508 | 52.667 | 70.693 |
Total Common Shares Outstanding | 121.811 | 107.168 | 107.168 | 106.191 | 105.591 |
Other Current Assets, Total | 0.379 | 0.2 | 0.414 | 0.54 | 0.414 |
Totale Vorderingen, Netto | 0.793 | ||||
Accounts Receivable - Trade, Net | 0.793 |
- Jaarlijks
- Per kwartaal
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Netto-inkomen/Beginsaldo | -73.534 | -66.048 | -19.101 | -51.255 | -3.475 |
Geldmiddelen uit Operationele Activiteiten | -61.604 | -48.995 | -20.913 | -19.305 | -1.581 |
Geldmiddelen uit Operationele Activiteiten | |||||
Niet-Geldelijke Posten | 9.147 | 18.46 | 2.733 | 25.089 | 0.193 |
Cash Taxes Paid | 0 | 0 | 0 | 0 | 0 |
Contant Betaalde Rente | 0.011 | 0.01 | 0.011 | 0.016 | 0 |
Veranderingen in het Operationeel Kapitaal | 2.783 | -1.407 | -4.545 | 6.861 | 1.701 |
Geldmiddelen uit Investeringsactiviteiten | |||||
Kapitaaluitgaven | |||||
Overige Cash Flow investeringsposten, Totaal | |||||
Geldmiddelen uit Financieringsactiviteiten | -1.597 | 112.067 | 26.314 | 29.524 | 1.365 |
Uitgifte (Aflossing) van aandelen, netto | 0.564 | 125.618 | 15.26 | 29.524 | 0 |
Uitgifte (Aflossing) van Schulden, Netto | -1.888 | -13.551 | 11.054 | 0 | 1.365 |
Nettowijziging in Geldmiddelen | -63.201 | 63.072 | 5.401 | 10.219 | -0.216 |
Financiering van Cash Flow Posten | -0.273 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | -13.431 | -73.534 | -54.877 | -35.273 | -14.001 |
Cash From Operating Activities | -10.348 | -61.604 | -48.514 | -37.44 | -17.045 |
Non-Cash Items | 5.635 | 9.147 | 7.292 | 5.691 | 2.242 |
Cash Taxes Paid | 0 | 0 | 0 | 0 | |
Cash Interest Paid | 0.114 | 0.011 | 0.011 | 0.009 | 0.004 |
Changes in Working Capital | -2.552 | 2.783 | -0.929 | -7.858 | -5.286 |
Cash From Financing Activities | 8.874 | -1.597 | 0.291 | -0.043 | 0.083 |
Issuance (Retirement) of Stock, Net | 10.16 | 0.564 | 0.564 | 0.083 | 0.083 |
Issuance (Retirement) of Debt, Net | -1.286 | -1.888 | 0 | 0 | 0 |
Net Change in Cash | -1.474 | -63.201 | -48.223 | -37.483 | -16.962 |
Financing Cash Flow Items | -0.273 | -0.273 | -0.126 |
Naam investeerder | Type investeerder | Percentage uitstaand | Aandelen in bezit | Wijziging aandelen | Datum bezit | Omzetcijfer |
---|---|---|---|---|---|---|
Tontine Asset Management, LLC | Hedge Fund | 4.1606 | 5068020 | 159295 | 2023-03-31 | LOW |
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 4.1185 | 5016741 | 0 | 2023-03-31 | LOW |
Mehra Raj | Individual Investor | 2.694 | 3281546 | 201617 | 2023-03-27 | |
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 1.3543 | 1649727 | -136883 | 2023-03-31 | LOW |
Mirae Asset Global Investments (USA) LLC | Investment Advisor | 1.185 | 1443459 | 210996 | 2023-03-31 | LOW |
Horizons ETFs Management (Canada) Inc. | Investment Advisor/Hedge Fund | 1.185 | 1443459 | 210996 | 2023-03-31 | LOW |
Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 0.9342 | 1138001 | 22118 | 2023-03-31 | LOW |
Uniplan Investment Counsel, Inc. | Investment Advisor | 0.9251 | 1126815 | -50695 | 2023-03-31 | LOW |
Wealth Effects LLC | Investment Advisor | 0.7849 | 956046 | 956046 | 2023-03-31 | LOW |
MAI Capital Management, LLC | Investment Advisor/Hedge Fund | 0.7614 | 927422 | -94586 | 2023-03-31 | LOW |
Modera Wealth Management, LLC | Investment Advisor/Hedge Fund | 0.7155 | 871505 | 0 | 2023-03-31 | LOW |
Norges Bank Investment Management (NBIM) | Sovereign Wealth Fund | 0.6435 | 783800 | 0 | 2021-12-31 | LOW |
Millennium Management LLC | Hedge Fund | 0.513 | 624862 | -123123 | 2023-03-31 | HIGH |
AdvisorShares Investments, LLC | Investment Advisor | 0.3277 | 399133 | 26050 | 2023-03-31 | HIGH |
Morgan Stanley Smith Barney LLC | Investment Advisor | 0.284 | 345938 | 9000 | 2023-03-31 | LOW |
Group One Trading, L.P. | Research Firm | 0.2654 | 323326 | -963863 | 2023-03-31 | HIGH |
State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 0.2581 | 314405 | 0 | 2023-03-31 | LOW |
Northern Trust Investments, Inc. | Investment Advisor/Hedge Fund | 0.1608 | 195858 | 12207 | 2023-03-31 | LOW |
Davenport Asset Management | Investment Advisor | 0.1112 | 135500 | 0 | 2023-03-31 | LOW |
Strategic Family Wealth Counselors, L.L.C | Investment Advisor | 0.0919 | 112000 | 10000 | 2023-03-31 |
Waarom Capital.com? De cijfers spreken voor zichzelf.
Capital.com Group530K+
Handelaren
87K+
Actieve klanten per maand
$46M+
Maandelijks beleggingsvolume
$31M+
Opgenomen per maand
Handelscalculator
Bereken uw virtuele winst- en verliesrekening indien u een CFD-positie had geopend op een bepaalde datum (kies een datum) en gesloten op een andere datum (kies een datum).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
SEELOS THERAPEUTICS INC Company profile
Over SEELOS THERAPEUTICS INC
Seelos Therapeutics, Inc. is een biofarmaceutisch bedrijf in een klinische fase. De Vennootschap richt zich op de ontwikkeling van producten die tegemoetkomen aan de onbeantwoorde noden in aandoeningen van het centrale zenuwstelsel (CZS) en andere zeldzame aandoeningen. De lead programma's van de Vennootschap, SLS-002 voor de behandeling van acute suïcidale ideatie en gedrag (ASIB) bij depressieve stoornis (MDD), en SLS-005 voor de potentiële behandeling van amyotrofe laterale sclerose (ALS). SLS-005 voor de potentiële behandeling van Sanfilippo-syndromen, dat nog wordt onderzocht. De Vennootschap ontwikkelt ook verscheidene preklinische programma's, waaronder SLS-010, een orale histamine H3A-receptorantagonist die veelbelovende activiteit vertoont bij narcolepsie en verwante aandoeningen, en SLS-012, een injecteerbare therapie voor postoperatieve pijnbestrijding. De lopende programma's van de Vennootschap omvatten SLS-004, SLS-006, SLS-007 en SLS-008.
Industry: | Pharmaceuticals (NEC) |
300 Park Avenue
2Nd Floor
NEW YORK
NEW YORK 10022
US
Winst- en verliesrekening
- Annual
- Quarterly
Mensen bekijken ook
Nog steeds op zoek naar een broker die u kunt vertrouwen?
Sluit u aan bij de 530.000+ handelaren die er wereldwijd voor kozen om met Capital.com te handelen